Stay updated on Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial

Sign up to get notified when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New history entries show the study status and recruitment status were updated to terminated and closed due to slow accrual (dates 2026-02-10 and 2026-02-12). The previous 'Completed' status was deleted (2026-02-11).
    Difference
    0.6%
    Check dated 2026-02-18T16:35:48.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    New history entries show the study as Completed, with updated Study Status and Recruitment Status, and introduce Contacts/Locations and Study Design sections, with Revision: v3.4.2 recorded on 2026-02-11. The older government funding notice and the prior Recruiting entry (2025-07-03, Revision: v3.4.1) were removed.
    Difference
    2%
    Check dated 2026-02-11T14:15:03.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The study record history now shows a new revision (v3.4.1) replacing the previous revision (v3.4.0), and a government funding lapse notice is displayed on the page.
    Difference
    0.7%
    Check dated 2026-02-04T10:25:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A glossary toggle is added, diff highlights are color-coded (green for additions, red for deletions), and the revision label updates to v3.4.0.
    Difference
    0.9%
    Check dated 2026-01-28T06:22:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New history entry added: Revision: v3.3.4 appears in the Record History alongside prior revisions.
    Difference
    0.1%
    Check dated 2026-01-14T02:13:24.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T17:24:53.000Z thumbnail image

Stay in the know with updates to Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.